ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,608,933 | +151.7% | 707,028 | +125.8% | 0.04% | +150.0% |
| Q1 2023 | $1,036,487 | -53.5% | 313,138 | -45.5% | 0.01% | -60.0% |
| Q4 2022 | $2,231,225 | -33.0% | 575,058 | -79.0% | 0.04% | -7.9% |
| Q3 2022 | $3,331,328 | +6698.6% | 2,739,104 | +10859.9% | 0.04% | +3700.0% |
| Q2 2022 | $49,000 | -97.9% | 24,992 | -98.1% | 0.00% | -96.6% |
| Q1 2022 | $2,382,000 | +235.5% | 1,301,638 | +158.3% | 0.03% | +480.0% |
| Q4 2021 | $710,000 | – | 503,889 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |